Balyasny Asset Management
IART icon

Balyasny Asset Management’s Integra LifeSciences IART Stock Holding History

Balyasny Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.54M Buy
694,076
+557,791
+409% +$6.12M 0.01% 1246
2025
Q4 		$1.69M Buy
136,285
+111,165
+443% +$1.48M ﹤0.01% 1952
2025
Q3 		$360K Buy
+25,120
New +$344K ﹤0.01% 2516
2024
Q4 		– Sell
-614,682
Closed -$11.2M – 2974
2024
Q3 		$11.2M Buy
+614,682
New +$14.2M 0.02% 890
2024
Q2 		– Sell
-208,681
Closed -$7.4M – 2809
2024
Q1 		$7.4M Buy
208,681
+163,982
+367% +$6.56M 0.01% 1066
2023
Q4 		$1.95M Buy
44,699
+14,583
+48% +$574K ﹤0.01% 1460
2023
Q3 		$1.15M Sell
30,116
-215,455
-88% -$9.06M ﹤0.01% 1534
2023
Q2 		$10.1M Buy
245,571
+163,649
+200% +$7.88M 0.02% 773
2023
Q1 		$4.7M Buy
81,922
+49,386
+152% +$2.78M 0.01% 1104
2022
Q4 		$1.82M Sell
32,536
-179,540
-85% -$9.14M 0.01% 1460
2022
Q3 		$8.98M Buy
+212,076
New +$10.9M 0.03% 736
2021
Q2 		– Sell
-79,423
Closed -$5.49M – 2131
2021
Q1 		$5.49M Buy
+79,423
New +$5.38M 0.03% 666
2019
Q3 		– Sell
-32,841
Closed -$1.83M – 1357
2019
Q2 		$1.83M Buy
32,841
+11,577
+54% +$596K 0.01% 895
2019
Q1 		$1.19M Buy
+21,264
New +$1.08M 0.01% 965
2018
Q3 		– Sell
-3,489
Closed -$225K – 1832
2018
Q2 		$225K Buy
+3,489
New +$216K ﹤0.01% 1607
2015
Q3 		– Sell
-8,147
Closed -$224K – 1250
2015
Q2 		$224K Buy
+8,147
New +$217K ﹤0.01% 1001

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Balyasny Asset Management's IART Position: Q1 2026 in Review

Balyasny Asset Management increased its Integra LifeSciences (IART) stake by 409% in Q1 2026, buying an estimated $6.12M and bringing the position to 694,076 shares worth $6.54M. The position accounts for 0.01% of the portfolio, ranked #1246.

Balyasny Asset Management first reported a position in IART in Q2 2015 and has held it in 16 quarters since. The position peaked at $11.2M in Q3 2024. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Balyasny Asset Management held 694,076 shares of Integra LifeSciences worth $6.54M as of Q1 2026.
  • Balyasny Asset Management bought 557,791 Integra LifeSciences shares in Q1 2026, an estimated $6.12M.
  • Integra LifeSciences made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1246 holding.
  • Balyasny Asset Management first reported a position in Integra LifeSciences in Q2 2015 and has held it in 16 quarters since.
  • Balyasny Asset Management's Integra LifeSciences position peaked at $11.2M in Q3 2024.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.